CD40-CD40L interactions inatherosclerosis
- 1 June 1997
- journal article
- review article
- Published by Elsevier in Immunology Today
- Vol. 18 (6), 272-277
- https://doi.org/10.1016/s0167-5699(97)80022-9
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- A central role of CD40 ligand in the regulation of CD4+ T-cell responsesImmunology Today, 1996
- Accessory signaling by CD40 for T cell activation: induction of Th1 and Th2 cytokines and synergy with interleukin‐12 for interferon‐γ productionEuropean Journal of Immunology, 1996
- Cross-regulatory roles of interleukin (IL)-12 and IL-10 in atherosclerosis.JCI Insight, 1996
- Functions of CD40 and Its Ligand, gp39 (CD40L)Critical Reviews in Immunology, 1996
- CD40 Expression by human fibroblastsClinical Immunology and Immunopathology, 1995
- Activated T cells enhance nitric oxide production by murine splenic macrophages through gp39 and LFA‐1European Journal of Immunology, 1995
- Is atherosclerosis an immunologically mediated disease?Immunology Today, 1995
- Role of the CD40‐CD40 ligand interaction in CD4+ T cell contact‐dependent activation of monocyte interleukin‐1 synthesisEuropean Journal of Immunology, 1994
- Immune-deficient mice develop typical atherosclerotic fatty streaks when fed an atherogenic diet.JCI Insight, 1994
- CD40 expression by human monocytes: regulation by cytokines and activation of monocytes by the ligand for CD40.The Journal of Experimental Medicine, 1993